Navigation Links
Marken Shares Recent Client Survey Results

RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2017 /PRNewswire/ -- Marken has completed their annual survey of clients which has provided the company with positive support for their strategy and performance.  The survey was conducted by the Avoca Group, a leading industry research organization.  They conducted 100, 30-minute in-depth personal interviews with a range of large, small, new and legacy clients.

Overall satisfaction with Marken's services scored a mean 4.1 out of 5.0, with 98% of respondent's scores ranging from 'satisfied' to 'very satisfied'.  Clients cited the most important attributes where Marken scores highest are: global capabilities, geographic reach, commitment to hitting milestones, on-time delivery, flexibility to handle change, regulatory expertise and good understanding of client's needs.  89% of respondents agreed that Marken's range of services met their needs and that Marken has strong brand visibility in the market place.  Over 80% of respondents were pleased with Marken's global growth and agreed that Marken's new services were exactly what they expected.  In fact, they expressed a strong interest in: on-demand labeling services, kit building, regulatory support, ancillary materials management, bio sample storage, comparator sourcing and in-home patient care.  Many of these services are currently part of Marken's portfolio, and others are already included in Marken's business strategy.  Overall, respondents were 'likely' or 'very likely' to recommend Marken to others, with a strong 'net promoter score' of +37%.

Clients also reinforced the continued growth of the clinical logistics market.  Over 90% of respondents indicated that they would be growing their volume or their need for new services with Marken in the future, with a third of them indicating growth of 25% or more. This was considerably higher than previous surveys.

"We are very pleased with these survey results," said Wes Wheeler, Marken's Chief Executive.  "We routinely ask our clients for feedback about the quality of our services.  We use this feedback to improve our services and re-validate our short and long term business strategy.  With UPS behind us we will continue to invest in new locations, more resources and new services which meet the increasing demands of our clients.  We will do this while leveraging the enormous buying power of our new parent company."     

About Marken
Marken is a wholly owned subsidiary of UPS.  Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistic hubs in 45 locations worldwide for clinical trial material storage and distribution. Marken's more than 680 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries.  Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken's unique position in the pharma and logistics industry.

About the Avoca Group
Since its inception in 1999, The Avoca Group has delivered high-quality, actionable research to pharmaceutical companies, CROs and specialty service providers.  A pioneer in clinical outsourcing research and consulting, Avoca has tracked and influenced the progression of the sector, making it the ideal partner for companies seeking to better understand the dynamics of their business relationships.

To view the original version on PR Newswire, visit:

Copyright©2017 PR Newswire.
All rights reserved

Related biology technology :

1. Marken fue elegido como courier biológico preferido en América Latina
2. Marken Chosen As Preferred Biologic Courier In Latin America
3. Marken Ensures Safe Transportation Of Select Agents And Toxins
4. Telesta Therapeutics gibt Erteilung des MCNA-Stoffpatents durch das US-amerikanische Patent- und Markenamt bekannt
5. Marken schließt Ergebnisse für das Geschäftsjahr 2014 ab
6. Lupin weitet Marken-Portfolio aus
7. Marken Meets Critical Demand For In Vitro Lab Shipments
8. Bayer Shares the Risk with Cotton Growers
9. Intrexon Announces a Special Stock Dividend of Shares of AquaBounty Technologies
10. Asymmetrex Director Shares Vision for Company and Private Stem Cell Treatment Clinics in Two Arena International Event Group Forums
11. AltaVoice Shares Data on Diseases from its Patient Insights Network
Post Your Comments:
(Date:2/11/2020)... ... 2020 , ... Synagro Technologies, Inc. , the preeminent ... the City of Fort Worth has partnered with Synagro of Texas-CDR (Synagro) to ... 2020, Synagro will assume operation of the city’s current biosolids management facility and ...
(Date:2/3/2020)... ... February 03, 2020 , ... ... Firm Travel, Law Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. ... Each Index illustrates the following statistics:, Average airfare ...
(Date:1/28/2020)... ... January 28, 2020 , ... Today, Salimetrics announced an ... new Salivary Total Human IgG Assay Kit exemplifies Salimetrics’ 20+ year ... researchers can extend the accuracy and ease of use of salivary bioscience into ...
(Date:1/24/2020)... ... January 24, 2020 , ... The ... in biotechnology, diagnostics, therapeutics, laboratory and clinical services during the first two decades ... the world. And as Slone Partners celebrates its 20th anniversary this ...
Breaking Biology Technology:
(Date:1/29/2020)... ... January 29, 2020 , ... INDIGO Biosciences, Inc. (INDIGO), the ... announced a record earnings year for 2019. With final numbers to be released ... percent increase in revenue and a thirty percent increase in gross profit, and ...
(Date:1/28/2020)... ... January 28, 2020 , ... ... and government agencies, announced that the firm has established a presence in Cambridge, ... office will be in the Cambridge Innovation Center (CIC), at One Broadway in ...
(Date:1/27/2020)... (PRWEB) , ... January 27, 2020 , ... On Thursday, ... Information Solutions Life Sciences, Reed Tech and Richard Castle, Global Account Manager ... to discussing the procedure, other topics include EU MDR timing deadlines, best practices in ...
Breaking Biology News(10 mins):